Patients report improved energy levels, reduced appetite fluctuations, and more sustainable weight loss trajectories when using both agents
Given their effectiveness and expanding range of benefits, it is no wonder that GLP-1 receptor agonists are becoming an increasingly popular choice for both doctors and patients alike
Increased tear osmolarity in dry eye disease has been found to stimulate production of inflammatory cytokines and matrix metalloproteinases by ocular surface epithelial cells [155]
8-12 hours IM) Preferred by 64% of patients who've tried both Intramuscular (into deltoid or vastus lateralis, using a 22-25 gauge, 1-inch needle): 41% report injection-site soreness Faster absorption More difficult self-administration for some sites (deltoid requires non-dominant arm injection) Preferred by 36% of patients who've tried both The efficacy difference is minimal
I was not sick and I was able to lose weight in just one month
What are oral GLP-1 therapies and how do they help with weight loss